ISTANBUL, Turkey -- Cisplatin-Navelbine (vinorelbine) reduced mortality in fully resected non-small cell lung cancer (NSCLC), according to a meta-analysis reported here.
Rabiya Tuma, Ph.D.
Advertisement
Articles by Rabiya Tuma, Ph.D.
ISTANBUL, Turkey -- Progression-free survival is prolonged by 10% in men with locally advanced prostate cancer who receive both radiation and hormone therapy, according to a large meta-analysis.
ISTANBUL, Turkey -- A blood test may be able to distinguish between a malignancy in the lung and a benign pulmonary pathology, researchers reported here.
ATLANTA ? With a new class of drugs, researchers are on the trail of killer receptors on the surface of cancer cells.
Advertisement
Latest Updated Articles
- ASCO: New Drug Class Triggers Tumor Cell Death
Published: June 4th 2006 | Updated:
- ESMO: Radiation Plus Hormone Therapy Is Prostate Cancer Plus
Published: October 6th 2006 | Updated:
- ESMO: Cisplatin-Navelbine Duo Shows Survival Edge in NSCLC
Published: October 6th 2006 | Updated:
- ESMO: Blood Test May Screen for Lung Cancer
Published: October 3rd 2006 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
7 Drugs Approved for Primary Care: Q3 2025
2
Mazdutide Demonstrates Superior Glycemic Control and Weight Loss vs Semaglutide in Head-to-Head Trial
3
FAQs On The Critical Window Hypothesis for Menopausal Hormone Therapy's Neuroprotective Effects
4
Why Do Women Suffer in Silence with Genitourinary Syndrome of Menopause?
5
